Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease

被引：24
作者：
Huff-Hardy, Kayci [1 ]
Bedair, Mai [2 ]
Vazquez, Rebecca [2 ]
Burstein, Ezra [1 ]
机构：
[1] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX 75390 USA
[2] UT Southwestern Med Ctr, Dept Dermatol, Dallas, TX USA
来源：
INFLAMMATORY BOWEL DISEASES | 2017年 / 23卷 / 10期
关键词：
MAINTENANCE THERAPY; INDUCTION;
D O I：
10.1097/MIB.0000000000001232
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E49 / E49
页数：1
相关论文
共 50 条
  • [41] Real-World Evidence Comparing Vedolizumab and Ustekinumab in Antitumor Necrosis Factor-Experienced Patients With Crohn's Disease
    Kappelman, Michael D.
    Adimadhyam, Sruthi
    Hou, Laura
    Wolfe, Audrey E.
    Smith, Samantha
    Simon, Andrew L.
    Moyneur, Erick
    Reynolds, Juliane S.
    Toh, Sengwee
    Dobes, Angela
    Parlett, Lauren E.
    Haynes, Kevin
    Selvan, Mano
    Ma, Qianli
    Nair, Vinit
    Burris, Jessica
    Dorand, Jennifer E.
    Dawwas, Ghadeer K.
    Lewis, James D.
    Long, Millie D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (04) : 674 - 684
  • [42] Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naive Crohn's Disease
    Narula, Neeraj
    Wong, Emily C. L.
    Dulai, Parambir S.
    Sengupta, Neil K.
    Marshall, John K.
    Colombel, Jean-Frederic
    Reinisch, Walter
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (07) : 1579 - +
  • [43] Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab
    Yarur, Andres J.
    McGovern, Dermot
    Abreu, Maria T.
    Cheifetz, Adam
    Papamichail, Konstantinos
    Deepak, Parakkal
    Bruss, Alexandra
    Beniwal-Patel, Poonam
    Dubinsky, Marla
    Targan, Stephan R.
    Melmed, Gil Y.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (11) : 2908 - 2917
  • [44] Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment
    Biemans, Vince B. C.
    van der Woude, C. Janneke
    Dijkstra, Gerard
    van der Meulen-de Jong, Andrea E.
    Lowenberg, Mark
    de Boer, Nanne K.
    Oldenburg, Bas
    Srivastava, Nidhi
    Jansen, Jeroen M.
    Bodelier, Alexander G. L.
    West, Rachel L.
    de Vries, Annemarie C.
    Haans, Jeoffrey J. L.
    de Jong, Dirk
    Hoentjen, Frank
    Pierik, Marieke J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (01) : 123 - 134
  • [45] Ustekinumab is effective in biological refractory Crohn's disease patients-regardless of approval study selection criteria
    Saman, Sadik
    Goetz, Martin
    Wendler, Judith
    Malek, Nisar P.
    Wehkamp, Tan
    Klag, Thomas
    INTESTINAL RESEARCH, 2019, 17 (03) : 340 - 348
  • [46] Exposure-efficacy relationship of vedolizumab subcutaneous and intravenous formulations in Crohn's disease and ulcerative colitis
    D'Haens, Geert
    Rosario, Maria
    Polhamus, Daniel
    Dirks, Nathanael L.
    Chen, Chunlin
    Kisfalvi, Krisztina
    Agboton, Christian
    Vermeire, Severine
    Feagan, Brian G.
    Sandborn, William J.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2024, 17 (04) : 403 - 412
  • [47] Vedolizumab Long-term Efficacy and Safety in the Treatment of ulcerative Colitis and Crohn's Disease in Adults
    不详
    VISCERAL MEDICINE, 2017, 33 (05) : 391 - 391
  • [48] Efficacy and safety of intravenous vedolizumab treatment in Chinese patients with moderate-to-severe Crohn's disease
    Chen, Minhu
    Gao, Xiang
    Cao, Qian
    Rossiter, Guillermo
    Kitagawa, Tadayuki
    Sun, Yue
    Yang, Lili
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2025, 49 (06)
  • [49] Efficacy and Safety of Natalizumab and Vedolizumab for the Management of Crohn's Disease: A Systematic Review and Meta-analysis
    Chandar, Apoorva K.
    Singh, Siddharth
    Murad, Mohammad Hassan
    Peyrin-Biroulet, Laurent
    Loftus, Edward V., Jr.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (07) : 1695 - 1708
  • [50] Efficacy of Ustekinumab Optimization by 2 Initial Intravenous Doses in Adult Patients With Severe Crohn's Disease
    Ren, Haixia
    Kang, Jian
    Wang, Jing
    Su, Juan
    Zou, Liping
    Yin, Anning
    Li, Jiao
    Zhou, Qian
    Wang, Wei
    Tang, Zhishun
    Zhang, Jing
    Lu, Yueyue
    Yang, Yuanping
    Qiu, Chengen
    Ding, Yijuan
    Dong, Weiguo
    An, Ping
    INFLAMMATORY BOWEL DISEASES, 2023, 30 (08) : 1295 - 1302
12345